We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in the Cards for Universal Health's (UHS) Q2 Earnings?
Read MoreHide Full Article
Universal Health Services, Inc. (UHS - Free Report) is slated to report second-quarter 2021 results on Jul 26, after the closing bell. The company beat estimates in each of the trailing four quarters.
Factors to Note
Universal Health’s second-quarter revenues are likely to reflect the benefits of improving patient volumes, resumption of elective or scheduled procedures and better patient days. The Zacks Consensus Estimate for the company’s second-quarter revenues is pegged at $3 billion, which indicates growth of 10.8% from the prior-year reported figure.
Strong performances at the Acute Care Hospital Services and Behavioral Health Care Services segments might have contributed to the to-be-reported quarter’s top line as well. Increased admissions are likely to have driven performances at both the segments in the second quarter.
The consensus mark for net revenues at both the segments suggests rise of 18.7% and 8.3%, respectively, from the year-ago quarter.
While the Zacks Consensus Estimate for patient days in Acute Care Hospitals highlights 21.9% improvement from the prior-year reported figure, the consensus estimate for Behavioral Health Centers reflects growth of 5.4% compared with the prior-year quarter. The metric is expected to have gained on the back of rebounding patient volumes in the to-be-reported quarter.
The consensus mark for average licensed beds at Acute Care Hospitals indicates growth of 1% from the prior-year quarter. Meanwhile, the same for Behavioral Health Centers suggests an improvement of 1.9% from the year-ago quarter’s reported number.
Per the company’s last earnings call, the board of directors sanctioned recommencement of its share buyback program in the second quarter.
However, Universal Health might have encountered elevated costs due to higher salaries, wages and other operating expenses. These costs are likely to have weighed on the to-be-reported quarter’s bottom line.
The Zacks Consensus Estimate for second-quarter earnings stands at $2.75, which suggests a decline of 6.1% from the prior-year quarter.
What Our Quantitative Model Predicts
The proven Zacks model does not conclusively predict an earnings beat for Universal Health this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here.
Earnings ESP: Universal Health has an Earnings ESP of -0.36%. This is because the Most Accurate Estimate of $2.74 is pegged lower than the Zacks Consensus Estimate of $2.75. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Universal Health Services, Inc. Price and EPS Surprise
Some stocks worth considering from the medical space with a perfect combination of elements to surpass estimates in the upcoming quarterly releases are as follows:
Image: Bigstock
What's in the Cards for Universal Health's (UHS) Q2 Earnings?
Universal Health Services, Inc. (UHS - Free Report) is slated to report second-quarter 2021 results on Jul 26, after the closing bell. The company beat estimates in each of the trailing four quarters.
Factors to Note
Universal Health’s second-quarter revenues are likely to reflect the benefits of improving patient volumes, resumption of elective or scheduled procedures and better patient days. The Zacks Consensus Estimate for the company’s second-quarter revenues is pegged at $3 billion, which indicates growth of 10.8% from the prior-year reported figure.
Strong performances at the Acute Care Hospital Services and Behavioral Health Care Services segments might have contributed to the to-be-reported quarter’s top line as well. Increased admissions are likely to have driven performances at both the segments in the second quarter.
The consensus mark for net revenues at both the segments suggests rise of 18.7% and 8.3%, respectively, from the year-ago quarter.
While the Zacks Consensus Estimate for patient days in Acute Care Hospitals highlights 21.9% improvement from the prior-year reported figure, the consensus estimate for Behavioral Health Centers reflects growth of 5.4% compared with the prior-year quarter. The metric is expected to have gained on the back of rebounding patient volumes in the to-be-reported quarter.
The consensus mark for average licensed beds at Acute Care Hospitals indicates growth of 1% from the prior-year quarter. Meanwhile, the same for Behavioral Health Centers suggests an improvement of 1.9% from the year-ago quarter’s reported number.
Per the company’s last earnings call, the board of directors sanctioned recommencement of its share buyback program in the second quarter.
However, Universal Health might have encountered elevated costs due to higher salaries, wages and other operating expenses. These costs are likely to have weighed on the to-be-reported quarter’s bottom line.
The Zacks Consensus Estimate for second-quarter earnings stands at $2.75, which suggests a decline of 6.1% from the prior-year quarter.
What Our Quantitative Model Predicts
The proven Zacks model does not conclusively predict an earnings beat for Universal Health this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here.
Earnings ESP: Universal Health has an Earnings ESP of -0.36%. This is because the Most Accurate Estimate of $2.74 is pegged lower than the Zacks Consensus Estimate of $2.75. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Universal Health Services, Inc. Price and EPS Surprise
Universal Health Services, Inc. price-eps-surprise | Universal Health Services, Inc. Quote
Zacks Rank: The company carries a Zacks Rank #3.
Stocks to Consider
Some stocks worth considering from the medical space with a perfect combination of elements to surpass estimates in the upcoming quarterly releases are as follows:
Molina Healthcare, Inc. (MOH - Free Report) has an Earnings ESP of +2.40% and a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Illumina, Inc. (ILMN - Free Report) has an Earnings ESP of +2.36% and a Zacks Rank #2, currently.
Encompass Health Corporation (EHC - Free Report) has an Earnings ESP of +0.33% and a Zacks Rank of 2, presently.